Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acid Calcium Phosphate
2. Calcium Bisphosphate
3. Calcium Phosphate, Monobasic
4. Calcium Superphosphate
5. Monocalcium Orthophosphate
1. 7758-23-8
2. Monocalcium Phosphate
3. Calcium Dihydrogen Phosphate
4. Calcium Dihydrogen Orthophosphate
5. Monobasic Calcium Phosphate
6. Acid Calcium Phosphate
7. Monocalcium Orthophosphate
8. Calcium Dihydrogenphosphate
9. Primary Calcium Phosphate
10. Monocalcium Phosphate, Monobasic
11. Calcium Monobasic Phosphate
12. Calcium Bis(dihydrogen Phosphate)
13. Calcium Phosphate (1:2)
14. Calcium Phosphate, Monobasic
15. Phosphoric Acid, Calcium Salt (2:1)
16. Calcium;dihydrogen Phosphate
17. 701ekv9rmn
18. Calcium Phosphate Monobasic Anhydrous
19. Calcium Phosphate, Monobasic, Anhydrous
20. C 38 (phosphate)
21. Calcium Diorthophosphate
22. Calcium Tetrahydrogen Phosphate
23. Calcium Bis(dihydrogenphosphate)
24. Hsdb 1441
25. Calcium Tetrahydrogen Orthophosphate
26. Calcium Dihydrogenphoshate
27. Calcium Bis(dihydrogenorthophosphate)
28. Einecs 231-837-1
29. Unii-701ekv9rmn
30. V 90
31. Calcium Hydrogen Phosphate (ca(h2po4)2)
32. Calcium Bisphosphate
33. Calciumphosphatemonobasic&n
34. Dihydromonocalcium Phosphate
35. Ec 231-837-1
36. Ca(h2po4)2
37. Dtxsid2044262
38. Ins No.341(i)
39. Chebi:35433
40. Ins-341(i)
41. Akos015902863
42. Calcium Bis(dihydrogenorthophosphate), With A Fluorine Content Of Less Than 0,005 % By Weight On The Dry Anhydrous Product
43. Calcium Phosphate, Monobasic [mi]
44. E-341(i)
45. Calcium Dihydrogen Phosphate [inci]
46. Calcium Dihydrogen Tetraoxophosphate
47. Calcium Phosphate Monobasic [who-dd]
48. Ft-0623378
49. Monobasic Calcium Phosphate, Anhydrous
50. Calcium Bis(dihydrogen Phosphate) [hsdb]
51. Q414673
Molecular Weight | 234.05 g/mol |
---|---|
Molecular Formula | CaH4O8P2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 233.9007319 g/mol |
Monoisotopic Mass | 233.9007319 g/mol |
Topological Polar Surface Area | 161 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 49.8 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
/Ortho/ phosphate is absorbed from, and to a limited extent secreted into, the gastrointestinal tract. The transport of phosphate from the lumen of the gut is an active, energy-dependent process, and there are factors that appear to modify the degree of its intestinal absorption. ... Vitamin D stimulates phosphate absorption, and this effect has been reported to precede the action of the vitamin on transport of calcium ion. In general, in adults, about two thirds of the ingested phosphate is absorbed from the bowel, and that which is absorbed from the gut is almost entirely excreted into the urine. In growing children, there is a positive balance of phosphate. Concentrations of phosphate in plasma are higher in children than in adults. This "hyperphosphatemia" decreases the affinity of hemoglobin for oxygen and is hypothesized to explain the physiological "anemia" of childhood. /Phosphates/
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1501
A defect in phosphate metabolism occurs in a variety of diseases. ... Osteoporosis ... Rickets ... Osteomalacia ... Osteitis Fibrosa Cystica ... Secondary Hyperparathyroidism ... Hypoparathyroidism ... . /Phosphates/
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1503
ABOUT THIS PAGE
A Calcium Biphosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Biphosphate, including repackagers and relabelers. The FDA regulates Calcium Biphosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Biphosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Biphosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium Biphosphate supplier is an individual or a company that provides Calcium Biphosphate active pharmaceutical ingredient (API) or Calcium Biphosphate finished formulations upon request. The Calcium Biphosphate suppliers may include Calcium Biphosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Biphosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Calcium Biphosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Biphosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Biphosphate GMP manufacturer or Calcium Biphosphate GMP API supplier for your needs.
A Calcium Biphosphate CoA (Certificate of Analysis) is a formal document that attests to Calcium Biphosphate's compliance with Calcium Biphosphate specifications and serves as a tool for batch-level quality control.
Calcium Biphosphate CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Biphosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Biphosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Biphosphate EP), Calcium Biphosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Biphosphate USP).
LOOKING FOR A SUPPLIER?